ΔN p73 Antibodies

Santa Cruz Biotechnology features a diverse variety of ΔN p73 monoclonal antibodies for advanced research in cell biology and cancer studies. ΔN p73 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ΔN p73 is a member of the p53 family of proteins and plays a crucial role in regulating cell cycle progression and apoptosis. Unlike its full-length counterpart, ΔN p73 lacks the transactivation domain, which allows it to act as a dominant-negative regulator of p53 and p73, influencing tumorigenesis and cellular response to stress. Understanding ΔN p73 function is vital for elucidating its role in cancer development and progression. Research involving ΔN p73 has revealed significant insights into cellular mechanisms and potential therapeutic targets. Investigating ΔN p73 expression patterns helps researchers better understand various cancer types and their progression. ΔN p73 studies continue to uncover new pathways in cancer biology and potential treatment strategies. Santa Cruz Biotechnology monoclonal antibodies for ΔN p73 support researchers worldwide in their quest to advance cancer research and therapeutic development.